Targeted attack: new combo therapy tested for tough bladder cancers
NCT ID NCT04003610
Summary
This study aimed to see if a new drug combination (pemigatinib plus pembrolizumab) worked better than standard care for people with advanced bladder cancer who cannot take cisplatin and have a specific genetic change (FGFR3). It was a Phase 2 trial that was terminated early, enrolling only 7 participants. The goal was to control the cancer's growth and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azosp S.Maria Sc Oncologia
Terni, 05100, Italy
-
Barts Health Nhs Trust - St Bartholomews Hospital
London, EC1A 7BE, United Kingdom
-
Centre Hospitalier Universitaire de Besancon
Besançon, 25000, France
-
Centre Hospitalier Universitaire de Poitiers
Poitiers, 86021, France
-
Champalimaud Foundation - Champalimaud Centre For the Unknown (Champalimaud Cancer Center)
Lisbon, 1400-048, Portugal
-
Charleston Hematology Oncology Associates
Charleston, South Carolina, 29414, United States
-
Chiba Cancer Center
Chiba, 260-8717, Japan
-
Chiba University Hospital
Chiba, 260-8677, Japan
-
Christiana Care Helen F. Graham Cancer Center
Newark, Delaware, 19713, United States
-
Chu Nimes
Nîmes, 30029, France
-
Chu de Strasbourg Hopitaux Universitaires Service D Hematologie
Strasbourg, 67091, France
-
Cotton-O'Neil Clinical Research Center, Hematology & Oncology
Marietta, Georgia, 30067, United States
-
Fakultna Nemocnica S Poliklinikou Zilina
Žilina, 01207, Slovakia
-
Fondazione Irccs Ca Granda Ospedale Maggiore
Milan, 20122, Italy
-
Fondazione Irccs Istituto Nazionale Dei Tumori
Milan, 20133, Italy
-
Fonk Onkologian Klinikka
Tampere, 33520, Finland
-
Grand Hopital de Charleroi
Charleroi, 06000, Belgium
-
Groupe Hospitalier Pellegrin Tripode
Bordeaux, 33075, France
-
Groupe Hospitalier Pitie-Salpetriere
Paris, 75013, France
-
Hakodate Goryokaku Hospital
Hokkaido, 040-8611, Japan
-
Helsinki University Meilahti Tower Hospital
Helsinki, 00029, Finland
-
Hirosaki University Hospital
Hirosaki-shi, 036-8563, Japan
-
Hopital Cochin Cancerologie
Paris, 75014, France
-
Hopital Europeen Georges Pompidou (Hegp)
Paris, 75015, France
-
Hospital Clinic I Provincial
Barcelona, 08036, Spain
-
Hospital Clinico San Carlos
Madrid, 28040, Spain
-
Hospital Clinico Universitario de Valencia
Valencia, 46010, Spain
-
Hospital Puerta de Hierro
Majadahonda, 28222, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Hm Sanchinarro
Madrid, 28050, Spain
-
Hospital Universitario Virgen Del Rocio
Seville, 41013, Spain
-
Hospital Universitario de La Paz
Madrid, 28046, Spain
-
Ico Girona
Girona, 17007, Spain
-
Ico Institut Catala D Oncologia
Barcelona, 08908, Spain
-
Ieo Istituto Europeo Di Oncologia Irccs
Milan, 20141, Italy
-
Institut Claudius Regaud Oncopole Toulouse
Toulouse, 31100, France
-
Iov - Istituto Oncologico Veneto Irccs
Bari, 70124, Italy
-
Irrcs Instituto Clinico Humanitas
Rozzano, 20089, Italy
-
Istituto Nazionale Tumori Fondazione Irccs G. Pascale
Naples, 80131, Italy
-
Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori
Meldola, 47014, Italy
-
Istituto Tumori Giovanni Paolo Ii Irccs Ospedale Oncologico Bari
Bari, 70124, Italy
-
Jichi Medical University Hospital
Shimotsuke-shi, 329-0498, Japan
-
Kagawa University Hospital
Kita-gun, 761-0793, Japan
-
Keio University Hospital
Shinjuku-ku, 160-8582, Japan
-
Kliniken Maria Hilf
Mönchengladbach, 41063, Germany
-
L AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA POLICLINICO S. ORSOLA � MALPIGHI
Bologna, 40138, Italy
-
Marin Cancer Care
Greenbrae, California, 94904, United States
-
Moncton Hospital - Horizon Health Network
Moncton, New Brunswick, E1C 6Z8, Canada
-
Mount Sinai School of Medicine
New York, New York, 10029, United States
-
Nara Medical University Hospital
Kashihara-shi, 634-8522, Japan
-
National Cancer Center Hospital
Tokyo, 104-0045, Japan
-
National Hospital Organization Kyushu Cancer Center
Fukuoka, 811-1395, Japan
-
Nho Shikoku Cancer Center
Matsuyama, 791-0280, Japan
-
Nihon University Itabashi Hospital
Itabashi-ku, 173-8610, Japan
-
Olsztynski Osrodek Onkologiczny Kopernik
Olsztyn, 10-513, Poland
-
Onc Consultants Pharmacy 2
Houston, Texas, 77030, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Osaka International Cancer Institute
Osaka, 541-8567, Japan
-
Osaka University Hospital
Suita-shi, 565-0871, Japan
-
Polyclinique de Blois
La Chaussée-Saint-Victor, 41260, France
-
Saitama Medical Center Jichi Medical University
Saitama-shi, 330-8503, Japan
-
Saitama Medical University International Medical Center
Hidaka-shi, 350-1298, Japan
-
Sapporo Medical University Hospital
Hokkaido, 060-8543, Japan
-
Simmons Cancer Institute At Siu
Springfield, Illinois, 62702, United States
-
Smhc Cancer Blood Disorders
Biddeford, Maine, 04005, United States
-
Spitalul Clinic Judetean de Urgenta 'Sf Apostol Andrei' Constanta
Constanța, 900591, Romania
-
St. Marianna University School of Medicine Hospital
Kawasaki-shi, 216-8511, Japan
-
Summit Medical Group
Florham Park, New Jersey, 07932, United States
-
The Center For Cancer and Blood Disorders
Fort Worth, Texas, 76104, United States
-
The University of Kansas Cancer Center
Westwood, Kansas, 66205, United States
-
Tohoku University Hospital
Sendai, 980-8574, Japan
-
Toranomon Hospital
Minatoku, 105-8470, Japan
-
Toyama University Hospital
Toyama, 930-0194, Japan
-
Turku University Hospital, Sct Unit
Turku, 20521, Finland
-
UNIVERSIT� CAMPUS BIO-MEDICO DI ROMA
Roma, 00128, Italy
-
Universitaire Ziekenhuis Leuven - Gasthuisberg
Leuven, 03000, Belgium
-
University Hospital Waterford
Waterford, X91 ER8E, Ireland
-
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232, United States
-
Wilhelminenspital
Vienna, 01160, Austria
Conditions
Explore the condition pages connected to this study.